PANACEABIO
Invest with MTF
Invest Now
Invest in Panacea Biotec with 2.25X leverage
Panacea Biotec live price: ₹317.2. It opened at ₹322 vs previous close ₹317; intraday high/low: ₹326/₹314. The 50 & 200 DMA stand at ₹351.48/₹381.14.
Panacea Biotec Performance
- Low
- ₹314
- High
- ₹326
- 52 Week Low
- ₹305
- 52 Week High
- ₹582
- Open Price₹322
- Previous Close₹317
- Volume93,113
- 50 DMA₹351.48
- 100 DMA₹368.15
- 200 DMA₹381.14
Investment Returns
- Over 1 Month -8.55%
- Over 3 Month -9.72%
- Over 6 Month -27%
- Over 1 Year -19.6%
Smart Investing Starts Here Start SIP with Panacea Biotec for Steady Growth!
Panacea Biotec Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -249.7
- PEG Ratio
- -151.9
- Market Cap Cr
- 1,943
- P/B Ratio
- 2.3
- Average True Range
- 16.64
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -8.75
- RSI
- 37.88
- MFI
- 55.17
Panacea Biotec Financials
Panacea Biotec Technicals
EMA & SMA
Current Price
₹317.20
+
0.4
(0.13%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹336.29
- 50 Day
- ₹351.48
- 100 Day
- ₹368.15
- 200 Day
- ₹381.14
Resistance and Support
319.17
- R3 335.73
- R2 330.87
- R1 324.03
- S1 312.33
- S2 307.47
- S3 300.63
Panacea Biotec Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-11 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend | |
| 2025-02-14 | Quarterly Results |
Panacea Biotec F&O
About Panacea Biotec
- NSE Symbol
- PANACEABIO
- BSE Symbol
- 531349
- Chairman & Managing Director
- Dr. Rajesh Jain
- ISIN
- INE922B01023
Similar Stocks to Panacea Biotec
Panacea Biotec FAQs
Panacea Biotec share price is ₹317 As on 17 March, 2026 | 18:13
The Market Cap of Panacea Biotec is ₹1942.9 Cr As on 17 March, 2026 | 18:13
The P/E ratio of Panacea Biotec is -249.7 As on 17 March, 2026 | 18:13
The PB ratio of Panacea Biotec is 2.3 As on 17 March, 2026 | 18:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.